SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
");background-position:center;background-size:19px 19px;background-repeat:no-repeat;background-color:var(--button-bg-color);padding:0;width:var(--form-elem-height);height:var(--form-elem-height);font-size:0;}:is(.js-newsletter-wrapper, .newsletter_bar.newsletter-wrapper) .widget__body:has(.response:not(:empty)) :is(.widget__headline, .widget__subheadline, #mc_embed_signup .mc-field-group, #mc_embed_signup input[type="submit"]){display:none;}:is(.grey_newsblock .newsletter-wrapper, .newsletter-wrapper) #mce-responses:has(.response:not(:empty)){grid-row:1 / -1;grid-column:1 / -1;}.newsletter-wrapper .widget__body > .snark-line:has(.response:not(:empty)){grid-column:1 / -1;}:is(.grey_newsblock .newsletter-wrapper, .newsletter-wrapper) :is(.newsletter-campaign:has(.response:not(:empty)), .newsletter-and-social:has(.response:not(:empty))){width:100%;}.newsletter-wrapper .newsletter_bar_col{display:flex;flex-wrap:wrap;justify-content:center;align-items:center;gap:8px 20px;margin:0 auto;}.newsletter-wrapper .newsletter_bar_col .text-element{display:flex;color:var(--shares-color);margin:0 !important;font-weight:400 !important;font-size:16px !important;}.newsletter-wrapper .newsletter_bar_col .whitebar_social{display:flex;gap:12px;width:auto;}.newsletter-wrapper .newsletter_bar_col a{margin:0;background-color:#0000;padding:0;width:32px;height:32px;}.newsletter-wrapper .social_icon:after{display:none;}.newsletter-wrapper .widget article:before, .newsletter-wrapper .widget article:after{display:none;}#sFollow_Block_0_0_2_0_0_0_1{margin:0;}#sSHARED_-_Social_Desktop_0_0_10_0_0_0.row-wrapper{margin:40px auto;}#sBoost_post_0_0_0_0_0_0_1_0{background-color:#000;color:#fff;}.boost-post{--article-direction:column;--min-height:none;--height:auto;--padding:24px;--titles-width:calc(100% - 84px);--image-fit:cover;--image-pos:right;--photo-caption-size:12px;--photo-caption-space:20px;--headline-size:23px;--headline-space:18px;--subheadline-size:13px;--text-size:12px;--oswald-font:"Oswald", Impact, "Franklin Gothic Bold", sans-serif;--cta-position:center;overflow:hidden;margin-bottom:0;--lora-font:"Lora", sans-serif !important;}.boost-post:not(:empty):has(.boost-post-article:not(:empty)){min-height:var(--min-height);}.boost-post *{box-sizing:border-box;float:none;}.boost-post .posts-custom .posts-wrapper:after{display:none !important;}.boost-post article:before, .boost-post article:after{display:none !important;}.boost-post article .row:before, .boost-post article .row:after{display:none !important;}.boost-post article .row .col:before, .boost-post article .row .col:after{display:none !important;}.boost-post .widget__body:before, .boost-post .widget__body:after{display:none !important;}.boost-post .photo-caption:after{content:"";width:100%;height:1px;background-color:#fff;}.boost-post .body:before, .boost-post .body:after{display:none !important;}.boost-post .body :before, .boost-post .body :after{display:none !important;}.boost-post__bottom{--article-direction:row;--titles-width:350px;--min-height:346px;--height:315px;--padding:24px 86px 24px 24px;--image-fit:contain;--image-pos:right;--headline-size:36px;--subheadline-size:15px;--text-size:12px;--cta-position:left;}.boost-post__sidebar:not(:empty):has(.boost-post-article:not(:empty)){margin-bottom:10px;}.boost-post__in-content:not(:empty):has(.boost-post-article:not(:empty)){margin-bottom:40px;}.boost-post__bottom:not(:empty):has(.boost-post-article:not(:empty)){margin-bottom:20px;}@media (min-width: 1024px){#sSHARED_-_Social_Desktop_0_0_10_0_0_0_1{padding-left:40px;}}.donation_banner{position:relative;background:#000;}.donation_banner .posts-custom *, .donation_banner .posts-custom :after, .donation_banner .posts-custom :before{margin:0;}.donation_banner .posts-custom .widget{position:absolute;inset:0;}.donation_banner__wrapper{position:relative;z-index:2;pointer-events:none;}.donation_banner .donate_btn{position:relative;z-index:2;}#sSHARED_-_Support_Block_0_0_13_0_0_3_1_0{color:#fff;}#sSHARED_-_Support_Block_0_0_13_0_0_3_1_1{font-weight:normal;}#sElement_Post_Layout_Press_Release__0_0_1_0_0_11{margin:100px 0;}.grey_newsblock .newsletter-wrapper, .newsletter-wrapper, .newsletter-wrapper.sidebar{background:linear-gradient(91deg, #005dc7 28%, #1d63b2 65%, #0353ae 85%);}.black_newsletter{background:linear-gradient(91deg, #005dc7 28%, #1d63b2 65%, #0353ae 85%);}.black_newsletter .newsletter_bar.newsletter-wrapper{background:none;}
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
Today, the Associated Press reported that the Drug Enforcement Administration (DEA) is proposing rescheduling marijuana from a Schedule I drug, the most restrictive class, to a Schedule III drug, a less restrictive class. Under this proposed shift, marijuana criminalization would continue at the federal level and most penalties, including those for simple possession, would continue as long as marijuana remains anywhere on the Controlled Substances Act (CSA). On the 2020 campaign trail, then-candidate Biden repeatedly pledged to decriminalize marijuana and expunge related criminal records – identifying these issues as barriers to racial equity. However, the DEA’s proposal would leave most of the harms and racial disparities associated with criminalization unaddressed.
“Supporting federal marijuana decriminalization means supporting the removal of marijuana from the Controlled Substances Act, not changing its scheduling” said Cat Packer, Director of Drug Markets and Legal Regulation. “We all deserve a federal framework for marijuana that upholds the health, wellbeing, and safety of our communities – particularly Black communities who have borne the brunt of our country’s racist enforcement of marijuana laws. Rescheduling marijuana is not a policy solution for federal marijuana criminalization or its harms, and it won’t address the disproportionate impact that it has had on Black and Brown communities.”
Packer continued: “The individuals, families and communities adversely impacted by federal marijuana criminalization deserve more. Workers in the marijuana industry, people who use marijuana, all of us deserve more. Congress and the Biden Administration have a responsibility to take actions now to bring about marijuana reform that meaningfully improves the lives of people who have been harmed by decades of criminalization. Descheduling and legalizing marijuana the right way isn’t just good policy, it’s popular with voters, too.”
A majority of American voters support marijuana legalization and comprehensive reform, according to a Data for Progress poll. Policymakers, health professionals and criminal justice advocates agree that marijuana must be removed from the CSA and coupled with comprehensive Congressional legislative reform to address racial disparities, reduce harm, and move toward a federal marijuana policy and regulatory framework that benefits all communities. Descheduling has also amassed significant support in Congress, with Representatives Blumenauer (D-OR), Joyce (R-OH), Lee (D-CA), and Mast (R-FL) leading their Congressional colleagues in two letters (in December 2022 and October 2023) to the DEA calling for descheduling marijuana, and Senator Warren (D-MA) leading eleven of her colleagues, including Senate Majority Leader Chuck Schumer (D-OH), urging President Biden’s Administration to remove marijuana from the CSA.
The Drug Policy Alliance and its coalition partners at United for Marijuana Decriminalization (UMD) plan to launch an ambitious outreach effort to encourage community members to tell President Biden and the DEA that marijuana must be descheduled once the public comment period is open. Members of the public will be able to submit comments in support of descheduling in response to the DEA’s proposal through a simple online form. During the brief, time-limited public comment period, UMD aims to solicit a historic number of public comments through extensive outreach to stakeholders, particularly those who have been harmed by marijuana criminalization, inviting participation in the public process and emphasizing the need for marijuana descheduling.
To end federal marijuana criminalization and create marijuana laws grounded in health, safety, and racial equity, the Drug Policy Alliance, fellow advocates, and Congressional leaders are calling on the DEA to deschedule marijuana by fully removing it from the CSA. While descheduling is critical to eliminating the ongoing harms of federal criminalization, marijuana reform can also take place through Executive Orders and Congressional legislation. President Biden can come closer to fulfilling his promise to end marijuana criminalization by taking immediate action to mitigate the harms of marijuana prohibition in people’s lives.
Additionally, Congressional legislation should provide relief from previous marijuana convictions, restore rights and benefits to people impacted by marijuana criminalization, reinvest in communities disproportionately harmed by criminal enforcement. Additionally, Congressional legislation should create a regulatory framework rooted in equity that prioritizes public health, workplace safety, and fair economic opportunities for small businesses. The House of Representatives has twice passed the Marijuana Opportunity Reinvestment and Expungement (MORE) Act, a comprehensive descheduling bill with extensive criminal justice reform and community reinvestment. In 2022, the Senate introduced the Cannabis Administration and Opportunity Act (CAOA), the most comprehensive Congressional descheduling bill to date.
Rep. Barbara Lee (CA):
“While the rescheduling of marijuana is a historic step in the right direction, anything short of descheduling falls woefully short of remedying the harms of the current system and the failed racist War on Drugs,” said Rep. Lee. “Rescheduling would allow for the criminal penalties for recreational and medical marijuana use to continue – disproportionately impacting Black and Brown communities. The criminalization of marijuana is also increasingly out of step with state law and public opinion. We need full descheduling and to pass the MORE Act – which I proudly co-lead – as a solution for equitable comprehensive marijuana reform rooted in racial and restorative justice.”
Senator Kirsten Gillibrand (NY):
“Descheduling marijuana from the Controlled Substances Act is not just a social justice issue; it’s an economic, medical, and public safety issue. Since marijuana was classified as a Schedule I substance during the war on drugs, countless lives have been torn apart, and individuals in primarily Black and brown communities have been targeted for nonviolent cannabis-related offenses,” said Senator Gillibrand. “Studies show that legalizing marijuana could help reduce violence in international drug trafficking and generate billions of dollars for the economy. The vast majority of Americans agree that marijuana should be legalized – that’s why I’m calling on the Attorney General and the Drug Enforcement Administration to swiftly deschedule marijuana from the Controlled Substances Act.”
Rep. Jerry Nadler (NY):
“While rescheduling marijuana is an important step, we must go further. It is time to end the prohibition and criminalization of marijuana at the federal level. That’s why I have introduced the Marijuana Opportunity Reinvestment and Expungement Act, or the MORE Act, which would not only decriminalize marijuana under federal law, but it would also expunge federal marijuana convictions and encourage states to do the same. The bill would also establish a fund to support programs assisting those communities who were most directly harmed by the War on Drugs and ensure that they have equal access to the benefits of decriminalization.”
Amber Senter, Co-Founder, Board Chair, and Executive Director, Supernova Women:
“There’s no doubt that the United States government recognizing cannabis has medicinal benefits is anything short of historic. Advocates have worked tirelessly for decades to reach this moment, banding together as patients, caregivers, social justice activists, and community members. However rescheduling cannabis to Schedule 3 is not enough. People will continue to be criminalized and punished for possessing and consuming cannabis, risking employment, housing, benefits and more. Workers in the cannabis industry will run the risk of federal prosecution for simply going to work and trying to provide for themselves and their families. Patients using cannabis as medicine through legal or state medical programs will also run the risk of federal criminalization by simply choosing a less harmful way to cope with pain from debilitating medical conditions. The war on drugs will continue to rage on, destroying lives and families as it’s done for decades. As a business owner in cannabis, I recognize the much-needed tax relief that rescheduling cannabis to Schedule 3 will bring. However, we cannot continue to allow some to capitalize from cannabis while others, primarily black and brown people, continue to be punished with their lives ruined. We must deschedule cannabis and stop criminalization for a medically beneficial plant.”
Chelsea Higgs Wise, Executive Director, Marijuana Justice:
“Since prohibiting marijuana there has been a targeted enforcement that has left communities of color disproportionately harmed at the individual, familial and community level. Rescheduling only brings benefits to businesses through tax relief, while our loved ones are left with the guarantee of repetitive surveillance, imprisonment, and collateral consequences. Any federal reform must directly address the disproportionate enforcement Black families continue to face. Presidential pardons are important but for true repair, we must continue to demand for marijuana to be descheduled along with people released and records expunged.”
Michelle Rutter Friberg, Director of Government Affairs, National Cannabis Industry Association:
“While rescheduling marijuana to Schedule III will undoubtedly provide much needed tax relief to cannabis businesses, the Biden Administration and Congress must act to deschedule marijuana and remove it from the Controlled Substances Act entirely. Only descheduling marijuana will harmonize federal law with the 37 states with some form of legal cannabis commerce, allow for the implementation of sensible regulations on hemp and marijuana derived products, and create a level playing field for small and minority owned businesses in the industry.”
Dr. Rachel Knox, MD, MBA, Board Chair, Association for Cannabis Health Equity and Medine (ACHEM):
“Cannabis must be removed from the Controlled Substances Act. From inception, its scheduling has been public health enemy #1, as it has underpinned decades of racist and classist provocation, perpetuating systemic harms directly linked to generational poverty and escalating health disparities in marginalized communities. Rescheduling does nothing to unravel this framework and, in fact, will allow it to continue unchecked. The only remedy to this chronic threat is descheduling, the swift overhaul of discriminatory cannabis policies across all sectors, and thoughtful regulation of diverse cannabis markets with standards rooted in science and social justice.”
Lt. Diane Goldstein (Ret.), Executive Director, Law Enforcement Action Partnership:
“As the failed policies of marijuana prohibition continue to drag on and waste law enforcement resources, the DEA’s move to reschedule marijuana to a less restrictive class would simply not go far enough,” she said. “It would not end federal marijuana criminalization and would do little to rectify the harms of the current system, in which an arrest record can lead to fewer employment opportunities, limited housing options, and obstacles to obtaining loans, all of which make people more, not less, disposed to crime and further drug use. The only way to end this unnecessary criminalization and its harms is to completely remove marijuana from the Controlled Substances Act.”
Dasheeda Dawson, Chair, Cannabis Regulators of Color Coalition and Founding Director, Cannabis NYC:
“The time for descheduling cannabis is not just a matter of policy; it’s an imperative for justice and equity. Rescheduling would undermine the hard-fought progress made by cannabis equity and policy reform leaders like the Cannabis Regulators of Color Coalition, jeopardizing the livelihoods and futures of those entrepreneurs and communities disproportionately affected by past criminalization. We cannot afford to backtrack on our commitment to repair the harm inflicted by outdated policies. Descheduling is not just about legality; it’s about rectifying historic injustices and ensuring a fair and inclusive future for all.”
Weldon Angelos, President & Co-Founder, The Weldon Project:
”As an advocate for ending federal marijuana prohibition, I acknowledge that the DEA’s decision to reschedule marijuana as a Schedule 3 substance is a significant step – but it’s far from the inevitable ultimate destination where marijuana is no longer treated as contraband in America’s failed war on drugs. Only the complete descheduling of marijuana will begin to dismantle the barriers of a nationwide criminal ban and ensure that no further damage is inflicted after decades of misguided federal policies. As we navigate this pivotal moment, our actions must be bold and unequivocal to ensure justice and equity for all those who have suffered under the weight of prohibition. If our ultimate goals are to liberate and restore American communities, now is not the time to settle for half measures or, worse yet, to declare victory and pretend like everything’s been solved. It hasn’t.”
Background:
38 states have laws that allow for medical cannabis use and 24 states have laws that allow for adult recreational cannabis use. Despite these reforms at the state level – as long as marijuana is a scheduled substance under the CSA, the repercussions of federal marijuana criminalization will continue – even for conduct that is authorized under state law. Individuals could still face criminal penalties, including mandatory minimum sentences, for personal use and distribution. Additionally, under a Schedule III classification, people with marijuana-related convictions could still lose access to federal housing and food benefits, or even face deportation. According to the ACLU, over 80% of people sentenced for federal marijuana charges were Black or Latino. This is a clear indication that maintaining federal criminalization in any form will perpetuate racially discriminatory policing and enforcement.
The Drug Policy Alliance is the nation's leading organization promoting drug policies grounded in science, compassion, health and human rights.
(212) 613-8020"As the Israeli military weaponizes AI for oppression, the world must confront this hypocrisy and hold it accountable to save lives," said Jewish Voice for Peace.
Amid reporting that the Israel Defense Forces is using an artificial intelligence weapons system touted as improving "operator lethality," Jewish Voice for Peace said Israel's use of technological warfare is "nothing new"—but pointed out that the new reports follow the country's signing of "the first global 'safety' AI treaty."
The Framework Convention on Artificial Intelligence, spearheaded by the Council of Europe, was signed by Israel in September, and "claims to be a legal framework governing AI systems to mitigate risks to human rights, democracy, and the rule of law—but the Israeli military is using AI to do precisely the opposite," said JVP.
The Jewish-led advocacy group spoke out after Middle East Eye (MEE)reported that the IDF has been using a weapons system in Gaza that came out of a collaboration between Israeli Weapons Industries and the Indian company Adani Defence & Aerospace.
The AI system, Arbel, was first unveiled at a defense expo in Gandhinagar, Gujarat in October 2022. MEE reported it is capable of turning "machine guns and assault rifles into computerized killing machines," using algorithms to increase Israeli soldiers' chances of hitting targets with accuracy and "efficiency."
The huge death toll in Gaza—which is conservatively estimated to be about 44,000 but which nearly 100 medical professionals estimated to be more than 118,000 last month, based on their experiences in hospitals there—has previously been linked to Israel's use of AI.
As Common Dreams reported in April, an AI machine called Lavender has been used by the IDF to devise "kill lists," with the military deeming 100 civilian deaths for every Hamas official an acceptable error rate. In December, the Israeli outlets +972 Magazine and Local Callreported that another AI machine called Gospel has been used to target dozens of buildings per day.
Defense analysts told MEE that Arbel has likely been used to "carry out the carnage of Palestinians in a more efficient manner in Gaza."
Antony Loewenstein, an independent journalist who tracks the use of technological warfare in Gaza and the West Bank, told MEE that as Israel has used numerous AI systems over the past 13 months, "targeting civilians was the point. It was never about just going after Hamas."
"I have spoken to people in Gaza, I have seen the direct human impact of this kind of killing," he told the outlet. "It is horrific."
Research analyst Noah Sylvia of the Royal United Services Institute in London told MEE that the IDF "has demonstrated a disregard for civilian life in Gaza to the point of routinely targeting children with small arms, meaning that Arbel could easily be used to make the killing of civilians, of children, more efficient."
The impact of the AI system depends "on the military's operating procedures and commitment to international humanitarian law," said Sylvia.
Humanitarian groups and human rights experts have said Israel is blatantly disregarding international law with its near-total blockade of aid into Gaza and its attacks—some with U.S. weapons—on civilians infrastructure.
JVP said the IDF's use of Arbel indicates Israel is also violating the Framework Convention on Artificial Intelligence, and noted reports that the military has also used "facial recognition technology and advanced weapons to monitor, silence dissent, cut internet access, and obscure its war crimes."
Marwa Fatafta, Middle East policy and advocacy director for Access Now, warned that Israel's partnering with India—where AI companies reportedly have the sixth-highest AI investments in the world at $7.73 billion—may provide "a new and terrifying blueprint for tech-enabled warfare... this time through Indian-Israel military tech."
"Rarely does a technology stay dormant in one location," Fatafta said. "The lawlessness and impunity in which Israel commits egregious crimes with the use of AI should terrify everyone."
"The U.S. must use its leverage to safeguard civilian lives, secure a lasting cease-fire, and advance a pathway toward peace."
A group of progressives in the U.S. House of Representatives on Wednesday endorsed Sen. Bernie Sanders' joint resolutions of disapproval that would block sales of American weapons to Israel as its troops continue to lay waste to the Gaza Strip.
Sanders (I-Vt.) introduced the six resolutions in September and plans to force a vote on Wednesday. In a statement led by Congressional Progressive Caucus Chair Rep. Pramila Jayapal (D-Wash.), the House members said that "if given the opportunity to do so, we would vote in favor of S.J. Res. 111, S.J. Res. 113, and S.J. Res. 115."
Jayapal was joined by Democratic Reps. Becca Balint (Vt.), Joaquin Castro (Texas), Lloyd Doggett (Texas), Sara Jacobs (Calif.), Barbara Lee (Calif.), Jim McGovern (Mass.), Mark Pocan (Wis.), and Jan Schakowsky (Ill.).
While condemning the Hamas-led October 7, 2023 attack and backing "defensive systems that are designed to meet Israel's security needs," the nine House members also argued that "the United States must use all available leverage, including the suspension of offensive weapons transfers, to de-escalate the violence and protect the lives of hostages, including Americans, Palestinian civilians, and all those impacted by the ongoing conflict."
"We are and have been deeply alarmed by the Israeli military's conduct in Gaza, where independent human rights monitors have documented the use of U.S.-provided weaponry in violations of international law," they continued. "According to the Biden administration's own report, 'it is reasonable to assess' that Israeli security forces have used U.S. weapons to violate international humanitarian law. The humanitarian aid entering Gaza has also reached historic lows. In October, an average of 28 trucks per day crossed into Gaza, compared to a pre-war daily average of 500."
The coalition also pointed to the Biden administration's mid-October letter, which threatened to cut off U.S. weapons unless the Israeli government took "urgent and sustained actions" to improve humanitarian conditions in Gaza within 30 days.
"On November 4, 2024, State Department Spokesperson Matthew Miller stated Israel had so far 'failed' to implement the recommendations in the letter, and that assessment was substantiated by several humanitarian organizations," the lawmakers noted. "Despite this clear lack of progress, no meaningful action has been taken by the Biden administration to promote Israeli compliance with stated U.S. policy goals."
Sanders announced plans to bring his resolutions to a vote after a U.S. State Department spokesperson last week responded to a question about the Biden administration's deadline by declaring that Israel is not violating federal and international law.
Warning that U.S. President-elect Donald Trump's return to the White House in January "will only embolden" Israeli Prime Minister Benjamin Netanyahu and his far-right ministers, the House members asserted that a vote for the resolutions "is a vote to politically restrain the Netanyahu government from any forthcoming efforts to formally annex the West Bank and settle parts of Gaza."
"We urge senators to support these joint resolutions of disapproval to block specific offensive arms sales to Israel, upholding U.S. law that prohibits arms transfers to countries that engage in a consistent pattern of gross violations of internationally recognized human rights or restrict the delivery of U.S. humanitarian assistance," the coalition concluded. "The U.S. must use its leverage to safeguard civilian lives, secure a lasting cease-fire, and advance a pathway toward peace."
Some House progressives have separately endorsed Sanders' resolutions. Rep. Cori Bush (D-Mo.)—who lost her August primary to a Democrat backed by pro-Israel lobbyists—said that since President Joe Biden "won't stop sending bombs, it's up to Congress to uphold the law" and urged "every senator who cares about humanity and the rule of law" to vote yes.
Rep. Rashida Tlaib (D-Mich.), the only Palestinian American in Congress, said on social media Wednesday, "Section 620I of the Foreign Assistance Act is very clear: The U.S. cannot provide weapons to any country that 'prohibits or otherwise restricts, directly or indirectly, the transport or delivery of United States humanitarian assistance.'"
Biden "has refused to enforce U.S. law and stop sending weapons to the Israeli government as they commit genocide in Gaza and use starvation as a weapon of war," Tlaib added. "Today, every senator will have to decide if they will vote to uphold our own laws and block arms sales to Israel."
So far, only a small number of senators have signaled support for the resolutions—Democratic Sens. Tim Kaine (Va.), Jeff Merkley (Ore.), Brian Schatz (Hawaii), Chris Van Hollen (Md.), Elizabeth Warren (Mass.), and Peter Welch (Vt.). The measures would also have to get through the Republican-controlled House to hit Biden's desk, and overriding an anticipated veto would require two-thirds support in both chambers.
Although the resolutions are not expected to pass even in the Senate, "the Biden administration is aggressively pushing senators to bless continued U.S. weapons shipments for Israel ahead of a first-of-its-kind vote in Congress on the policy," HuffPostrevealed Wednesday after obtaining a copy of talking points the White House is circulating on Capitol Hill.
"Administration officials are suggesting lawmakers who vote against the arms are empowering American and Israeli foes from Iran to the militant groups Hamas and Hezbollah, which the U.S. treats as terror organizations," HuffPost reported. "Senate Majority Leader Chuck Schumer (D-N.Y.) is also privately pressing senators to endorse the ongoing flow of military equipment to Israel, according to one of the aides."
Responding to the report on social media, Sanders ally and Arab American Institute president James Zogby—who is considering a run for Democratic National Committee chair—said that "this White House effort is disgraceful."
"Senators trying to block offensive weapons to Israel aren't aiding Hamas, they're trying to stop genocide, starvation, and massive violations of U.S. laws," Zogby added. "They're saving Palestinian lives and the last shred of U.S. honor."
"Dr. Oz wants to fully privatize Medicare," warned one advocacy group. "That’s why Donald Trump put him in charge of Medicare."
Dr. Mehmet Oz, whose unsuccessful 2022 Pennsylvania Senate bid included pitching voters on a plan to expand the privatized Medicare Advantage program, is now in a position to potentially actualize that plan.
President-elect Donald Trump announced Tuesday that Oz, also known by his TV personality name Dr. Oz, is his pick to lead the Centers for Medicare and Medicaid Services (CMS).
"Dr. Oz—a massive investor in Pharma—told the voters of Pennsylvania his plans to privatize Medicare… and they rejected him. Now Trump is giving him the authority to see his industry-approved plan carried through," wrote the progressive-leaning outlet The Lever, which covered Oz's support for Medicare Advantage back in 2022.
Through Medicare Advantage, which has been promoted by Trump and other congressional Republicans, seniors can opt out of traditional government-run Medicare health plans and instead choose plans administered by private insurers, such as UnitedHealthcare and Cigna.
According to The Lever's 2022 reporting, Oz pushed Medicare Advantage plans on his show The Dr. Oz Show and co-wrote a 2020 column for Forbes with a former healthcare executive in which they argued that a "Medicare Advantage For All" plan can "save" our healthcare system. In the column, Oz and his co-author articulated a plan to expand Medicare Advantage by imposing a 20% payroll tax.
Oz "is not a good pick for a very powerful position in charge of a trillion dollars of healthcare spending," wrote Matt Stoller of the American Economic Liberties Project on X, in reference to The Lever's investigation.
The Lever also reported that Oz's plan to expand private plans under Medicare Advantage could "boost companies in which he invests." For example, Oz and his wife owned up to $550,000 worth of stock in UnitedHealth Group, at the time of reporting. UnitedHealthcare and Humana account for nearly half, or 47%, of Medicare Advantage enrollees nationwide, according to the health policy organization KFF.
Additionally, a 2022 investigation by The New York Timesfound that major health insurers have exploited Medicare Advantage to boost their profits by billions of dollars.
Project 2025, a list of right-wing policy proposals led by the Heritage Foundation that Trump has tried to distance himself from, calls for making Medicare Advantage the default option for Medicare beneficiaries, which, if enacted, "would be a multibillion-dollar annual giveaway to corporations at the expense of Medicare enrollees and taxpayers," according to the liberal research and advocacy organization the Center for American Progress.
Robert Weissman, co-president of Public Citizen, offered a related critique of Oz: Americans "need someone who will crack down on insurers who want to deny care to the sick, providers who skimp on quality healthcare, corporations that want to privatize Medicare, and Big Pharma profiteers and ideologues who want to slash Medicaid and refuse care to low-income people. What they do not need is a healthcare huckster, which unfortunately Dr. Mehmet Oz appears to have become, having spent much of his recent career hawking products of dubious medical value."
In addition to the potential boon for private insurers, some researchers, news outlets, and members of Congress have also raised concerns about the quality of care administered under Medicare Advantage.
A 2022 government report found that "[Medicare Advantage Organizations] sometimes delayed or denied Medicare Advantage beneficiaries' access to services, even though the requests met Medicare coverage rules" and also "denied payments to providers for some services that met both Medicare coverage rules and [Medicare Advantage Organization] billing rules."
In October, a group of three Democratic lawmakers wrote to the current CMS administrator about increasingly widespread abuses and care denials by for-profit Medicare Advantage insurers.
"We are concerned that in many instances MA plans are failing to deliver, compromising timely access to care, and undermining the ability of seniors and Americans with disabilities to purchase the coverage that’s right for them," Sen. Ron Wyden (D-Ore.), Rep. Frank Pallone Jr. (D-N.J.), and Rep. Richard Neal (D-Mass.) wrote in a letter.
"We continue to hear alarming reports from seniors and their families, beneficiary advocates, and healthcare providers that MA plans are falling short, and finding a good plan is too difficult," they wrote.
In particular, they pointed to Medicare Advantage plans' growing reliance on prior authorization, a complex, barrier-ridden process whereby doctors must demonstrate a proposed treatment is medically necessary before the insurer will cover it.
"Overuse of prior authorization is not only harmful to patients, it hinders healthcare providers' ability to offer best-in-class service," they added.
Social Security Works, a progressive advocacy group, warned in a social media post Tuesday that "Dr. Oz wants to fully privatize Medicare."
"That's why Donald Trump put him in charge of Medicare," the group added. "We will fight to stop this charlatan from getting anywhere near our Medicare system."